Institutional Ownership Elevation Oncology, Inc. (ELEV)
This table provides information about the institutional ownership of Elevation Oncology, Inc. (ELEV). We have compiled data on the 68 institutions that hold shares in the stock, with a total of 45.4 Million shares, which have been reported (via 13F filing form) to have a value of $25.9 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
5,993,579
shares
|
$3.42 Million
0.19% of portfolio
|
Q3 2024
Added 102.58%
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
4,760,000
shares
|
$2.71 Million
0.24% of portfolio
|
Q3 2024
Added 55.56%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
3,988,472
shares
|
$2.27 Million
0.0% of portfolio
|
Q3 2024
Added 691.16%
|
|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
3,527,482
shares
|
$2.01 Million
0.01% of portfolio
|
Q3 2024
Reduced 1.97%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
3,071,580
shares
|
$1.75 Million
0.0% of portfolio
|
Q3 2024
Added 60.22%
|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
2,966,836
shares
|
$1.69 Million
0.06% of portfolio
|
Q3 2024
Added 28.31%
|
|
Aisling Capital Management LP
New York, NY |
Nov 13, 2024 Q3 2024 |
2,834,910
shares
|
$1.62 Million
0.7% of portfolio
|
Q2 2021
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,490,249
shares
|
$1.42 Million
0.0% of portfolio
|
Q2 2024
Added 1348.65%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
1,785,982
shares
|
$1.02 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Nov 13, 2024 Q3 2024 |
1,359,246
shares
|
$774,770
0.0% of portfolio
|
Q3 2024
Reduced 43.31%
|
|
Palo Alto Investors LP
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
1,298,097
shares
|
$739,915
0.11% of portfolio
|
Q3 2024
Reduced 27.89%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,110,085
shares
|
$632,748
0.0% of portfolio
|
Q3 2024
Added 7.61%
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Nov 14, 2024 Q3 2024 |
1,079,762
shares
|
$615,464
0.12% of portfolio
|
Q3 2024
Added 227.2%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,018,026
shares
|
$580,274
0.0% of portfolio
|
Q3 2024
Added 13.49%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
951,089
shares
|
$542,120
0.0% of portfolio
|
Q3 2024
Reduced 25.32%
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
941,275
shares
|
$536,526
0.01% of portfolio
|
Q1 2024
Reduced 37.25%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
785,450
shares
|
$447,706
0.0% of portfolio
|
Q3 2024
New holding
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
690,089
shares
|
$393,350
0.07% of portfolio
|
Q2 2024
Added 366.0%
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
652,188
shares
|
$371,747
0.0% of portfolio
|
Q3 2024
New holding
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
543,300
shares
|
$309,681
0.0% of portfolio
|
Q3 2024
Added 40.61%
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2024 Q3 2024 |
473,503
shares
|
$269,896
0.01% of portfolio
|
Q3 2024
Reduced 80.89%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
440,489
shares
|
$251,078
0.0% of portfolio
|
Q3 2024
Added 211.68%
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 05, 2024 Q3 2024 |
433,545
shares
|
$247,120
0.02% of portfolio
|
Q3 2024
New holding
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
373,228
shares
|
$212,739
0.0% of portfolio
|
Q3 2024
Added 284.54%
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
215,984
shares
|
$123,110
0.0% of portfolio
|
Q3 2024
Added 263.27%
|